Article

Multimodal predictors of disability progression and processing speed decline in relapsing-remitting multiple sclerosis

2025-02-12

Abstract excerpt

The underlying mechanisms for neurodegeneration in multiple sclerosis are complex and incompletely understood. Multivariate and multimodal investigations integrating demographic, clinical, multi-omics, and neuroimaging data provide opportunities for nuanced analyses, aimed to define disease progression markers. We used data from a 12-year longitudinal multicenter cohort of 88 people with multiple sclerosis, to tes...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c8182bcc-41d0-5e28-9c2e-8767ef7af89e
DOI: 10.1101/2025.02.09.25321961

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multimodal predictors of disability progression and processing speed decline in relapsing-remitting multiple sclerosisDOI 10.1101/2025.02.09.25321961Read

Molecular mechanisms associated with multiple sclerosis progression, severity and phenotypeSemantic proximity Read

Current status and future opportunities in modeling Multiple Sclerosis clinical characteristicsSemantic proximity Read

Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosisSemantic proximity Read

A taxonomy of cognitive phenotypes in Multiple Sclerosis: a 1-year longitudinal study.Semantic proximity Read

Metabolomic and Lipid Alterations are Associated with Longitudinal Neurological Performance in Multiple SclerosisSemantic proximity Read

The sequence of structural, functional and cognitive changes in multiple sclerosisSemantic proximity Read

A proposed new taxonomy of cognitive phenotypes in multiple sclerosis: The International Classification of Cognitive Disorders in MS (IC-CoDiMS).Semantic proximity Read

Multiple sclerosis diagnosis and phenotype identification by multivariate classification of in vivo frontal cortex metabolite profiles.Semantic proximity Read

Metabolomic Signatures of Brain Atrophy and Ibudilast Response in Progressive Multiple SclerosisSemantic proximity Read

Predominant cognitive phenotypes in multiple sclerosis: Insights from patient-centered outcomes.Semantic proximity Read

Predicting cognition using estimated structural and functional connectivity networks and artificial intelligence in multiple sclerosisSemantic proximity Read

Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisSemantic proximity Read